Literature DB >> 9364015

Simple identification of dominant p53 mutants by a yeast functional assay.

A Inga1, S Cresta, P Monti, A Aprile, G Scott, A Abbondandolo, R Iggo, G Fronza.   

Abstract

Analysis of families with germline p53 mutations shows that the mutant p53 allele behaves as a dominant oncogene at the genetic level, although it behaves as a recessive oncogene at the cellular level, since tumours invariably show mutation or loss of both wild-type alleles. At the biochemical level it is possible that some clinically important mutant p53 proteins may be carcinogenic through a dominant mechanism. We show that p53 mutants can be readily classified according to their dominant potential using a simple yeast functional assay. Wild-type p53 is constitutively expressed from a TRP1 vector, p53 mutants are expressed from an otherwise identical LEU2 vector and net transcriptional activity is scored using an ADE2-based reporter. Twenty seven p53 mutants were tested: 19 were recessive, i.e. gave white colonies, and eight showed dominant activity, i.e. gave pink/red colonies. This simple assay should facilitate studies on p53 dominance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364015     DOI: 10.1093/carcin/18.10.2019

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.

Authors:  Paola Monti; Chiara Perfumo; Alessandra Bisio; Yari Ciribilli; Paola Menichini; Debora Russo; David M Umbach; Michael A Resnick; Alberto Inga; Gilberto Fronza
Journal:  Mol Cancer Res       Date:  2011-02-22       Impact factor: 5.852

Review 2.  Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.

Authors:  Kanaga Sabapathy; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2017-09-26       Impact factor: 66.675

Review 3.  Functional analyses of human DNA repair proteins important for aging and genomic stability using yeast genetics.

Authors:  Monika Aggarwal; Robert M Brosh
Journal:  DNA Repair (Amst)       Date:  2012-02-18

Review 4.  p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours.

Authors:  R S Camplejohn; J Rutherford
Journal:  Cell Prolif       Date:  2001-02       Impact factor: 6.831

5.  p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.

Authors:  E Lopez-Crapez; F Bibeau; S Thézenas; M Ychou; J Simony-Lafontaine; A Thirion; D Azria; J Grenier; P Senesse
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

Review 6.  The Contrived Mutant p53 Oncogene - Beyond Loss of Functions.

Authors:  Kanaga Sabapathy
Journal:  Front Oncol       Date:  2015-12-10       Impact factor: 6.244

Review 7.  p53, p63 and p73 in the wonderland of S. cerevisiae.

Authors:  Marc Blondel; Cécile Voisset; Olivier Billant
Journal:  Oncotarget       Date:  2017-06-16

8.  The dominant-negative interplay between p53, p63 and p73: A family affair.

Authors:  Olivier Billant; Alice Léon; Solenn Le Guellec; Gaëlle Friocourt; Marc Blondel; Cécile Voisset
Journal:  Oncotarget       Date:  2016-10-25

9.  Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a prion, or form unstable liquid-like droplets.

Authors:  Sei-Kyoung Park; Sangeun Park; Christine Pentek; Susan W Liebman
Journal:  iScience       Date:  2020-12-29

10.  Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.

Authors:  Yari Ciribilli; Paola Monti; Alessandra Bisio; H Thien Nguyen; Abdul S Ethayathulla; Ana Ramos; Giorgia Foggetti; Paola Menichini; Daniel Menendez; Michael A Resnick; Hector Viadiu; Gilberto Fronza; Alberto Inga
Journal:  Nucleic Acids Res       Date:  2013-07-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.